(Date:11/30/2009)..., CHANGCHUN, China and LOS ANGELES, Nov. 30 /...ceuticals, Inc. (OTC Bulletin Board: CYXN; ,China ...ing manufacturer, distributor and,retailer of phar... it has,completed preparation for distribution of ...he Chinese government recently formalized the nati...
(Date:11/30/2009)... , SEATTLE, Nov. 30 C...) announced today that its new class of platinum-b...demonstrated a stronger anti-tumor potency and act...ed compounds as well as the ability to overcome ci...lts were presented in a paper titled "Novel Bis-pl...
(Date:11/30/2009)... , AMSTERDAM, November 3...leading publisher of scientific, medical and techn...r re-launch of Embase, its comprehensive biomedica...ords from more than 7,000,active, peer reviewed jo...le in the advancement of new biomedical,and pharma...
(Date:11/27/2009)... PARIS, November 27 S...market Oralair(R) in both adults and children,thro...irst country where,Oralair(R) has been marketed, w...R) is now registered in Austria, Belgium, Bulgaria...many, Greece, Hungary, Ireland, Italy,Latvia, Lit...
Breaking Biology Technology:China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 2New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents 3Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 2Elsevier is Re-Launching "Embase" to be a Powerful Resource Providing Deep Insights and Answers to Biomedical Researchers 3STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 2STALLERGENES is Granted a Marketing Authorization for Oralair(R) in Europe 3...LMINGTON, Del., July 23 More than a third,of the ...inquire about the,company,s prescription savings p... or pharmacists, according to a year-long survey o...at 35 percent of the patients who called,AstraZene...ings programs,said they were referred by healthcar...
...livers Solid Financial Performance While Building ...e Corporation,(Nasdaq: GENZ ) today reported stro...along with significant progress in its commercial ...ent to approximately $1.171 billion from,$933.4 mi...was driven by,growth across all areas of the busin...
...CKENSACK, N.J., July 16 - Over the past two decade... an experimental treatment,to one that is a viable...gnancies and other life-threatening blood disorder...nd Marrow Stem Cell Transplantation Program,at The...nter are,responsible for many of the innovations a...
Other Biology Technology:AstraZeneca Survey: Healthcare Professionals Leading Source of Information on Company's Prescription Savings Programs 2AstraZeneca Survey: Healthcare Professionals Leading Source of Information on Company's Prescription Savings Programs 3Genzyme Reports Strong Second-Quarter Growth 2Genzyme Reports Strong Second-Quarter Growth 3Genzyme Reports Strong Second-Quarter Growth 4Genzyme Reports Strong Second-Quarter Growth 5Genzyme Reports Strong Second-Quarter Growth 6Genzyme Reports Strong Second-Quarter Growth 7Genzyme Reports Strong Second-Quarter Growth 8Genzyme Reports Strong Second-Quarter Growth 9Genzyme Reports Strong Second-Quarter Growth 10Genzyme Reports Strong Second-Quarter Growth 11Genzyme Reports Strong Second-Quarter Growth 12Genzyme Reports Strong Second-Quarter Growth 13Genzyme Reports Strong Second-Quarter Growth 14Genzyme Reports Strong Second-Quarter Growth 15Genzyme Reports Strong Second-Quarter Growth 16Genzyme Reports Strong Second-Quarter Growth 17Stem Cell Transplantation Research at The Cancer Center at Hackensack University Medical Center Aims to Develop 'Designer' Transplants 2Stem Cell Transplantation Research at The Cancer Center at Hackensack University Medical Center Aims to Develop 'Designer' Transplants 3Stem Cell Transplantation Research at The Cancer Center at Hackensack University Medical Center Aims to Develop 'Designer' Transplants 4... The Rapid-Screen cDNA Library Panels were designe...ree sets of PCRs to identify the desired cDNA clon...l "Master Plate," where each well contains plasmid...tive well(s) by gel electrophoresis of the reactio...
... Idaho Technologys R.A.P.I.D. System (Ruggedized A...d, real-time, PCR thermocycler designed for field ...ironments. In addition to its ruggedness, it is de...e LightCycler instrument. By taking advantage of t...
... The Rapid-Screen cDNA Library Panels were designe...ree sets of PCRs to identify the desired cDNA clon...l "Master Plate," where each well contains plasmid...tive well(s) by gel electrophoresis of the reactio...
Ribonucleic acid, transfer from baker's yeast (S. cerevisiae) from Sigma-Aldrich
Biology Products: